Efficacy of pimavanserin for patients with psychosis in Parkinson’s disease: A systematic review. Research, Society and Development, [S. l.], v. 13, n. 1, p. e13713144895, 2024. DOI: 10.33448/rsd-v13i1.44895. Disponível em: https://rsdjournal.org/rsd/article/view/44895. Acesso em: 6 dec. 2025.